Contribution of systemic and somatic factors to clinical response and resistance in urothelial cancer: an exploratory multi-omic analysis. Contribution of systemic and somatic factors to clinical response and resistance in urothelial cancer: an exploratory multi-omic analysis
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA505572
下载链接
链接失效反馈官方服务：
资源简介：
Patients with metastatic urothelial cancer were treated with atezolizumab. Their tumors and matched normal blood were sequenced.
创建时间：
2018-11-15
